Global Diabetes Drugs Market by Drug Type (Injectable Drug, Oral Drug), Application (Type 1 Diabetes, Type 2 Diabetes) - Forecast 2024-2030- Product Image

Sale

Global Diabetes Drugs Market by Drug Type (Injectable Drug, Oral Drug), Application (Type 1 Diabetes, Type 2 Diabetes) - Forecast 2024-2030

Report
198 Pages
March 2024
Region: Global
360iResearch™
ID: 4989870

UP TO €852EUR$875USD£728GBP OFF until Dec 31^st 2024

The Diabetes Drugs Market size was estimated at USD 63.11 billion in 2023, USD 67.47 billion in 2024, and is expected to grow at a CAGR of 6.99% to reach USD 101.32 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Diabetes Drugs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Diabetes Drugs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Diabetes Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Astellas Pharma Inc., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb, Eli Lilly and Company, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., MannKind Corporation, Medtronic PLC, Merck KGaA, Novo Nordisk A/S, Pfizer Inc., Sanofi S.A., and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Diabetes Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

Drug Type
- Injectable Drug
  - Aspart
  - Exenatide
  - Glargine
  - Insulin
  - Leraglutide
  - Pramlintide
- Oral Drug
  - Alpha-Glucosidase Inhibitors
  - Biguanides
  - DPP-4 Inhibitors
  - Meglitinides & D-Phenylalanine Derivatives
  - Sulfonylureas
  - Thiazolidinediones
Application
- Type 1 Diabetes
- Type 2 Diabetes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Diabetes Drugs Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Diabetes Drugs Market?
What are the technology trends and regulatory frameworks in the Diabetes Drugs Market?
What is the market share of the leading vendors in the Diabetes Drugs Market?
Which modes and strategic moves are suitable for entering the Diabetes Drugs Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Diabetes Drugs Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increase in prevalence of diabetes disease
5.1.1.2. Rise in obesity coupled with unhealthy diets and sedentary lifestyles
5.1.1.3. Surge in the number of programs to create health awareness
5.1.2. Restraints
5.1.2.1. Side-effects of drugs in certain cases
5.1.3. Opportunities
5.1.3.1. Advancements in diabetic medications by pharmaceutical manufacturers
5.1.3.2. Rising investment in healthcare and development of healthcare infrastructure
5.1.4. Challenges
5.1.4.1. Lack of awareness among patients towards the availability of drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Diabetes Drugs Market, by Drug Type

6.1. Introduction
6.2. Injectable Drug
6.3.1. Aspart
6.3.2. Exenatide
6.3.3. Glargine
6.3.4. Insulin
6.3.5. Leraglutide
6.3.6. Pramlintide
6.3. Oral Drug
6.4.1. Alpha-Glucosidase Inhibitors
6.4.2. Biguanides
6.4.3. DPP-4 Inhibitors
6.4.4. Meglitinides & D-Phenylalanine Derivatives
6.4.5. Sulfonylureas
6.4.6. Thiazolidinediones

7. Diabetes Drugs Market, by Application

7.1. Introduction
7.2. Type 1 Diabetes
7.3. Type 2 Diabetes

8. Americas Diabetes Drugs Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Diabetes Drugs Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Diabetes Drugs Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
12.1.1. Abbott Laboratories
12.1.2. Astellas Pharma Inc.
12.1.3. Bayer AG
12.1.4. Boehringer Ingelheim International GmbH
12.1.5. Bristol Myers Squibb
12.1.6. Eli Lilly and Company
12.1.7. GlaxoSmithKline PLC
12.1.8. Johnson & Johnson Services, Inc.
12.1.9. MannKind Corporation
12.1.10. Medtronic PLC
12.1.11. Merck KGaA
12.1.12. Novo Nordisk A/S
12.1.13. Pfizer Inc.
12.1.14. Sanofi S.A.
12.1.15. Takeda Pharmaceutical Company Limited
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. DIABETES DRUGS MARKET RESEARCH PROCESS
FIGURE 2. DIABETES DRUGS MARKET SIZE, 2023 VS 2030
FIGURE 3. DIABETES DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. DIABETES DRUGS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. DIABETES DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. DIABETES DRUGS MARKET DYNAMICS
FIGURE 7. DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
FIGURE 8. DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS DIABETES DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS DIABETES DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES DIABETES DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES DIABETES DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC DIABETES DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC DIABETES DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DIABETES DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIABETES DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. DIABETES DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. DIABETES DRUGS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. DIABETES DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. DIABETES DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL DIABETES DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 6. DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 8. DIABETES DRUGS MARKET SIZE, BY ASPART, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. DIABETES DRUGS MARKET SIZE, BY EXENATIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. DIABETES DRUGS MARKET SIZE, BY GLARGINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. DIABETES DRUGS MARKET SIZE, BY INSULIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. DIABETES DRUGS MARKET SIZE, BY LERAGLUTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. DIABETES DRUGS MARKET SIZE, BY PRAMLINTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 16. DIABETES DRUGS MARKET SIZE, BY ALPHA-GLUCOSIDASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. DIABETES DRUGS MARKET SIZE, BY BIGUANIDES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. DIABETES DRUGS MARKET SIZE, BY DPP-4 INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. DIABETES DRUGS MARKET SIZE, BY MEGLITINIDES & D-PHENYLALANINE DERIVATIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. DIABETES DRUGS MARKET SIZE, BY SULFONYLUREAS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. DIABETES DRUGS MARKET SIZE, BY THIAZOLIDINEDIONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. DIABETES DRUGS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. DIABETES DRUGS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS DIABETES DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 32. ARGENTINA DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 35. BRAZIL DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 36. BRAZIL DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 37. BRAZIL DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. CANADA DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 39. CANADA DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 40. CANADA DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 41. CANADA DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. MEXICO DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 43. MEXICO DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 44. MEXICO DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 45. MEXICO DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES DIABETES DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. ASIA-PACIFIC DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 52. ASIA-PACIFIC DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 53. ASIA-PACIFIC DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 54. ASIA-PACIFIC DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. ASIA-PACIFIC DIABETES DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 56. AUSTRALIA DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 57. AUSTRALIA DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 58. AUSTRALIA DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 59. AUSTRALIA DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CHINA DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 61. CHINA DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 62. CHINA DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 63. CHINA DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. INDIA DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 65. INDIA DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 66. INDIA DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 67. INDIA DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. INDONESIA DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 69. INDONESIA DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 70. INDONESIA DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 71. INDONESIA DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. JAPAN DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 73. JAPAN DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 74. JAPAN DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 75. JAPAN DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 76. MALAYSIA DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 77. MALAYSIA DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 78. MALAYSIA DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 79. MALAYSIA DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. PHILIPPINES DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 81. PHILIPPINES DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 82. PHILIPPINES DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 83. PHILIPPINES DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. SINGAPORE DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 85. SINGAPORE DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 86. SINGAPORE DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 87. SINGAPORE DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. SOUTH KOREA DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 89. SOUTH KOREA DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 90. SOUTH KOREA DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 91. SOUTH KOREA DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. TAIWAN DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 93. TAIWAN DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 94. TAIWAN DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 95. TAIWAN DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. THAILAND DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 97. THAILAND DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 98. THAILAND DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 99. THAILAND DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. VIETNAM DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 101. VIETNAM DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 102. VIETNAM DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 103. VIETNAM DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA DIABETES DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 109. DENMARK DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 110. DENMARK DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 111. DENMARK DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 112. DENMARK DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 113. EGYPT DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 114. EGYPT DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 115. EGYPT DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 116. EGYPT DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. FINLAND DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 118. FINLAND DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 119. FINLAND DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 120. FINLAND DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. FRANCE DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 122. FRANCE DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 123. FRANCE DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 124. FRANCE DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. GERMANY DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 126. GERMANY DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 127. GERMANY DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 128. GERMANY DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. ISRAEL DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 130. ISRAEL DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 131. ISRAEL DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 132. ISRAEL DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. ITALY DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 134. ITALY DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 135. ITALY DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 136. ITALY DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. NIGERIA DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 142. NIGERIA DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 143. NIGERIA DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 144. NIGERIA DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. NORWAY DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 146. NORWAY DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 147. NORWAY DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 148. NORWAY DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. POLAND DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 150. POLAND DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 151. POLAND DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 152. POLAND DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 153. QATAR DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 154. QATAR DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 155. QATAR DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 156. QATAR DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 160. RUSSIA DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. SPAIN DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 170. SPAIN DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 171. SPAIN DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 172. SPAIN DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 173. SWEDEN DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 174. SWEDEN DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 175. SWEDEN DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 176. SWEDEN DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. SWITZERLAND DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 178. SWITZERLAND DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 179. SWITZERLAND DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 180. SWITZERLAND DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. TURKEY DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 182. TURKEY DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 183. TURKEY DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 184. TURKEY DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM DIABETES DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 190. UNITED KINGDOM DIABETES DRUGS MARKET SIZE, BY INJECTABLE DRUG, 2018-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM DIABETES DRUGS MARKET SIZE, BY ORAL DRUG, 2018-2030 (USD MILLION)
TABLE 192. UNITED KINGDOM DIABETES DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 193. DIABETES DRUGS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 194. DIABETES DRUGS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 195. DIABETES DRUGS MARKET LICENSE & PRICING

Companies Mentioned

Abbott Laboratories
Astellas Pharma Inc.
Bayer AG
Boehringer Ingelheim International GmbH
Bristol Myers Squibb
Eli Lilly and Company
GlaxoSmithKline PLC
Johnson & Johnson Services, Inc.
MannKind Corporation
Medtronic PLC
Merck KGaA
Novo Nordisk A/S
Pfizer Inc.
Sanofi S.A.
Takeda Pharmaceutical Company Limited

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	198
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 67.47 Billion
Forecasted Market Value ( USD ) by 2030	$ 101.32 Billion
Compound Annual Growth Rate	6.9%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3286EUR$3,374USD£2,809GBP €3651EUR$3,749USD£3,122GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4163EUR$4,274USD£3,559GBP €4625EUR$4,749USD£3,954GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5039EUR$5,174USD£4,308GBP €5599EUR$5,749USD£4,787GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5916EUR$6,074USD£5,058GBP €6573EUR$6,749USD£5,620GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7669EUR$7,874USD£6,556GBP €8521EUR$8,749USD£7,285GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

North America Diabetes Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

Asia-Pacific Diabetes Care Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

Diabetes Drugs: Global Strategic Business Report

Global Type 2 Diabetes Drugs Market by Drug (Injectables, Oral), Application (Cardiovascular Safety, Glycemic Control, Hypoglycemia Avoidance), Distribution - Forecast 2024-2030

Global Type 1 Diabetes Drug Market by Form (Insulin Therapy, Oral Medication), End User (Drugstore, Hospital) - Forecast 2024-2030

About the Diabetes Drugs Market